 |
| HIV /AIDS Clinical Stages |
Updated: August 2026
HIV does not affect everyone in exactly the same way.
Some people living with HIV have no symptoms when they are diagnosed. Others may already have illnesses linked to a weakened immune system.
The World Health Organization clinical staging system helps healthcare professionals classify HIV disease according to the clinical conditions a person has developed.
The system has four stages, from Stage 1, where a person may have no symptoms, to Stage 4, which includes severe HIV-related illnesses.
A person does not need to reach a particular WHO stage or CD4 count before starting HIV treatment.
Modern HIV treatment should be offered to everyone with a confirmed HIV diagnosis as soon as medically appropriate.
Clinical staging remains useful for assessing disease severity, identifying advanced HIV disease and helping healthcare professionals decide what additional investigations and care may be needed.
Quick Answer: What Are the Four WHO Clinical Stages of HIV?
The WHO staging system for adults and adolescents groups HIV disease into four clinical stages.
| WHO stage | General description | Examples |
|---|---|---|
| Stage 1 | Asymptomatic or very mild disease | No symptoms, persistent generalised lymphadenopathy |
| Stage 2 | Mild HIV-related disease | Moderate unexplained weight loss, recurrent respiratory infections, herpes zoster, recurrent oral ulcers |
| Stage 3 | Advanced HIV disease | Severe unexplained weight loss, persistent fever or diarrhoea, oral candidiasis, pulmonary tuberculosis, severe bacterial infections |
| Stage 4 | Severe HIV disease / AIDS-defining conditions | HIV wasting syndrome, Pneumocystis pneumonia, extrapulmonary TB, cryptococcal meningitis, cerebral toxoplasmosis, Kaposi sarcoma and other severe illnesses |
The actual staging system contains more clinical conditions than can be shown in a short summary table.
A healthcare professional determines the stage by assessing the person's symptoms, medical history, examination findings and investigations.
What Is HIV Clinical Staging?
Clinical staging is a way of describing how HIV has affected a person's health.
Before the advent of highly effective antiretroviral treatment and widespread access to laboratory monitoring, clinical staging was particularly important in settings where CD4 testing was unavailable.
It remains useful today.
Clinical stage can help identify people with serious HIV-associated illness and can contribute to recognising advanced HIV disease.
However, clinical staging should not be confused with HIV diagnosis.
A person's stage cannot tell you whether someone has HIV.
HIV infection must be established using appropriate HIV testing.
If you are looking for information about testing outside a health facility, read our guide to HIV Self-Testing in Nigeria: How It Works, Accuracy and What to Do Next.
WHO Clinical Stage 1: Asymptomatic HIV
Stage 1 is the earliest clinical category.
A person may feel completely well and have no obvious symptoms.
The main clinical features are:
Asymptomatic HIV infection
or
Persistent generalised lymphadenopathy, meaning enlarged lymph nodes in more than one area of the body that persist without another clear explanation.
Someone in Stage 1 can still have HIV multiplying in the body if they are not receiving effective treatment.
Feeling healthy does not mean HIV is inactive.
This is one reason HIV treatment should not be delayed until symptoms appear.
WHO Clinical Stage 2: Mild HIV Disease
Stage 2 includes relatively mild HIV-associated conditions.
These can include moderate unexplained weight loss, recurrent upper respiratory infections, herpes zoster or shingles, angular cheilitis, recurrent oral ulcers, papular pruritic eruptions and fungal nail infections.
These conditions do not automatically prove that someone has HIV.
Many can occur in people who do not have HIV.
Clinical staging is used after HIV infection has already been confirmed.
That distinction is important because people should not diagnose themselves with HIV simply because they develop shingles, weight loss or recurrent mouth ulcers.
WHO Clinical Stage 3: Advanced HIV Disease
Stage 3 represents more significant immune-system compromise.
Clinical conditions can include severe unexplained weight loss, unexplained chronic diarrhoea lasting more than one month, persistent unexplained fever, oral candidiasis, oral hairy leukoplakia, pulmonary tuberculosis and severe bacterial infections.
A person with HIV who has a WHO Stage 3 condition is considered to have advanced HIV disease, regardless of whether a CD4 result is immediately available.
Tuberculosis is particularly important because HIV and TB remain closely connected.
People living with HIV have a substantially increased risk of developing active tuberculosis when their immune system becomes weakened.
WHO continues to place strong emphasis on TB screening, prevention and treatment as part of HIV care.
WHO Clinical Stage 4: Severe HIV Disease
Stage 4 contains serious HIV-associated and AIDS-defining illnesses.
Examples include HIV wasting syndrome, Pneumocystis pneumonia, recurrent severe bacterial pneumonia, chronic herpes simplex infection, oesophageal candidiasis, extrapulmonary tuberculosis, Kaposi sarcoma, cryptococcal meningitis, cerebral toxoplasmosis, HIV encephalopathy, cytomegalovirus disease, lymphoma and several other severe opportunistic infections or malignancies.
These conditions can be life-threatening.
Anyone with suspected advanced HIV disease requires appropriate clinical assessment, investigation and management.
Modern HIV care aims to prevent people from reaching this stage by diagnosing HIV early, starting effective treatment and maintaining viral suppression.
Is WHO Stage 4 the Same as AIDS?
Stage 4 contains conditions associated with AIDS, the most advanced stage of untreated or uncontrolled HIV infection.
However, terminology around HIV has changed considerably.
Today, healthcare programmes increasingly focus on concepts such as:
advanced HIV disease
immune status
viral load
viral suppression
and
treatment response
rather than simply describing every person living with HIV as having AIDS.
A person diagnosed with an AIDS-defining condition can subsequently respond very well to treatment, achieve viral suppression and regain substantial immune function.
What Is Advanced HIV Disease?
WHO defines advanced HIV disease in adults and adolescents as either:
a CD4 count below 200 cells/mm³
or
WHO Clinical Stage 3 or Stage 4 disease.
This definition remains important because people with advanced HIV disease face a higher risk of serious illness and death.
The common serious conditions include tuberculosis, severe bacterial infections and cryptococcal meningitis.
People identified with advanced HIV disease may therefore need an additional package of screening, prevention, treatment and adherence support alongside antiretroviral therapy.
Is CD4 Count Still Important?
Yes.
But its role has changed.
In older HIV programmes, CD4 count was often used to decide when someone was eligible to begin ART.
That is no longer the main approach.
A confirmed HIV diagnosis is enough to make a person eligible for treatment.
CD4 testing remains especially useful for assessing immune function and identifying people with advanced HIV disease who may need additional clinical interventions.
This is one of the biggest corrections to the original 2017 version of this article.
Does HIV Treatment Depend on Clinical Stage?
No.
The old version of this article contained different ART thresholds for Stage 1, Stage 2, Stage 3 and Stage 4.
Those thresholds are outdated and should no longer be used.
WHO recommends antiretroviral therapy for everyone with confirmed HIV, irrespective of WHO clinical stage or CD4 count.
Treatment should generally begin as soon as medically appropriate after diagnosis and assessment.
Our full guide to Antiretroviral Treatment for HIV: How ART Works and What Patients Should Expect explains current HIV treatment in more detail.
Why Starting ART Early Matters
Without treatment, HIV continues reproducing and gradually damages the immune system.
Effective antiretroviral therapy suppresses HIV replication.
As viral load falls, the immune system can recover or remain stronger, and the risk of opportunistic infections and other HIV-related complications falls substantially.
Starting treatment before someone develops advanced disease is therefore preferable to waiting for severe symptoms.
What Is Viral Load?
Viral load measures the amount of HIV genetic material in the blood.
It is one of the most important tests used to monitor whether antiretroviral treatment is working.
When ART is taken consistently and remains effective, viral load usually falls dramatically.
A person may eventually achieve an undetectable viral load, meaning the amount of HIV in the blood is below the detection limit of the test being used.
This is different from clinical staging.
Clinical staging looks at illnesses and symptoms.
Viral load directly helps assess how well treatment is controlling HIV.
For a detailed explanation, read Viral Suppression and U=U: What an Undetectable HIV Viral Load Means.
Can Someone Be Stage 1 and Still Have a High Viral Load?
Yes.
Clinical symptoms and viral load do not always move together.
Someone can appear healthy and have few or no symptoms while HIV is still actively replicating.
This is one reason symptoms alone cannot be used to determine how well HIV is controlled.
Viral-load testing provides much better information about treatment response.
Can Someone Previously in Stage 4 Become Healthy Again?
Yes.
A person who previously developed a severe HIV-associated condition can respond very well to treatment.
Effective ART can suppress the virus, allow CD4 cells to recover and substantially reduce the risk of future opportunistic infections.
However, the person's previous clinical history remains medically important.
Someone does not simply erase a history of an AIDS-defining illness because treatment later works well.
Clinical Stage Is Not the Same as Treatment Failure
A person developing symptoms while receiving ART does not automatically mean the treatment regimen has failed.
Healthcare professionals may need to consider several possibilities, including another infection, medication adherence, immune recovery, drug interactions, resistance and viral-load results.
Treatment failure is primarily assessed using treatment response and virological information, not simply the WHO clinical stage.
This distinction is important enough to deserve its own article, which is why AnjKreb's existing HIV Treatment Failure page should remain separate from this staging guide.
What Is an Opportunistic Infection?
An opportunistic infection is an infection that occurs more frequently or becomes more severe when the immune system is weakened.
Examples associated with advanced HIV include tuberculosis, cryptococcal meningitis, Pneumocystis pneumonia and cerebral toxoplasmosis.
Effective ART dramatically reduces the risk of many opportunistic infections by helping restore immune function.
Some people with advanced HIV disease also require specific screening, preventive treatment or management for particular infections.
Why Tuberculosis Matters So Much in HIV Care
Tuberculosis remains one of the most serious infections affecting people living with HIV.
Someone with advanced immune suppression may develop pulmonary TB, extrapulmonary TB or disseminated disease.
WHO's updated 2026 HIV guidance continues to prioritise TB prevention for people living with HIV.
This is why routine HIV care often includes asking about symptoms suggestive of TB and assessing eligibility for tuberculosis preventive treatment.
What About Cotrimoxazole Preventive Therapy?
The original 2017 post repeatedly instructed readers to use “Septrin” or cotrimoxazole according to their clinical stage.
That framing is too simplistic.
Cotrimoxazole preventive therapy can be valuable for selected people living with HIV, particularly in settings or clinical circumstances where WHO or national guidance recommends it.
But eligibility depends on age, immune status, clinical condition, local epidemiology and national treatment guidance.
It should therefore be prescribed through HIV care rather than self-started based on an online staging table.
Does Clinical Staging Tell You How HIV Was Acquired?
No.
The WHO clinical stage provides information about disease severity.
It does not tell healthcare workers how someone acquired HIV.
HIV can be transmitted through specific exposures involving blood, sexual fluids and vertical transmission.
For a clear explanation of actual transmission routes and common myths, read How HIV Is Transmitted: Facts, Risks and Myths.
Why Clinical Staging Still Matters in Nigeria and Similar Settings
Clinical staging remains particularly valuable in health systems where access to laboratory testing may sometimes be delayed or limited.
A trained clinician can recognise important HIV-associated conditions and identify someone who may require urgent additional investigation or treatment.
But clinical judgement should not replace laboratory monitoring where laboratory services are available.
The strongest HIV care combines:
clinical assessment + viral-load monitoring + appropriate CD4 testing + treatment history + laboratory investigation when needed.
Clinical staging is therefore one tool within a broader system of HIV care.
Advanced HIV Disease Can Occur After Treatment Interruption
Advanced HIV disease is not limited to people who have never started ART.
It can also occur in someone returning to care after a prolonged treatment interruption or someone whose HIV is not adequately controlled.
This is another reason HIV programmes place so much emphasis on treatment continuity.
People who stop attending care should be supported to return without judgement.
Punitive or blaming approaches can make treatment interruption worse.
When Should Someone Living With HIV Seek Medical Care?
People living with HIV should remain connected to their treatment programme even when they feel completely well.
Prompt medical assessment is particularly important for persistent fever, significant unexplained weight loss, prolonged diarrhoea, difficulty breathing, severe headache, neurological symptoms, persistent mouth or swallowing problems, new severe skin lesions or other substantial changes in health.
These symptoms are not specific to HIV.
They need proper clinical evaluation.
Frequently Asked Questions
How many WHO clinical stages of HIV are there?
There are four clinical stages for adults and adolescents: Stage 1, Stage 2, Stage 3 and Stage 4.
Does Stage 1 HIV require treatment?
Yes.
All people with a confirmed HIV diagnosis should be offered antiretroviral therapy irrespective of their WHO stage or CD4 count.
Is Stage 4 HIV curable?
There is currently no routine cure that eliminates HIV from the body. However, people with severe HIV disease can respond well to effective ART and appropriate treatment of opportunistic infections.
Does a CD4 count below 200 mean advanced HIV disease?
Yes. WHO defines advanced HIV disease in adults and adolescents as a CD4 count below 200 cells/mm³ or WHO Clinical Stage 3 or 4.
Does Stage 3 automatically mean AIDS?
Stage 3 indicates advanced HIV disease. Stage 4 includes the most severe HIV-associated and AIDS-defining conditions.
Can someone with no symptoms have HIV?
Yes.
A person may be living with HIV and have no symptoms for a prolonged period. The only way to know HIV status is through appropriate testing.
Is viral load more important than clinical stage?
They answer different questions.
Clinical staging describes HIV-associated clinical illness. Viral load measures how much HIV is present in the blood and is essential for monitoring treatment response.
Can someone move from Stage 4 back to Stage 1?
Clinical history is not usually treated as though a previous severe HIV illness never happened. A person can become clinically well and achieve viral suppression after treatment, but previous AIDS-defining conditions remain important parts of their medical history.
Key Takeaways
The WHO HIV clinical staging system remains useful, but its role has changed.
Stage 1 generally represents asymptomatic disease, Stage 2 mild disease, Stage 3 advanced HIV disease and Stage 4 severe disease with AIDS-defining conditions.
Clinical stages are not used to decide whether someone deserves or qualifies for HIV treatment.
Everyone with confirmed HIV should be offered ART.
CD4 testing remains important for identifying advanced HIV disease, while viral-load testing is central to monitoring treatment effectiveness.
The goal of modern HIV care is not to wait for someone to progress through the stages.
It is to diagnose HIV early, start treatment promptly, maintain viral suppression and prevent advanced disease from developing.
Continue Reading on AnjKreb
Antiretroviral Treatment for HIV: How ART Works and What Patients Should Expect
Viral Suppression and U=U: What an Undetectable HIV Viral Load Means
HIV Self-Testing in Nigeria: How It Works, Accuracy and What to Do Next
How HIV Is Transmitted: Facts, Risks and Myths
References and Further Reading
World Health Organization. Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach.
https://www.who.int/publications/i/item/9789240031593
World Health Organization. WHO guidelines on the management of advanced HIV disease.
https://www.who.int/publications/i/item/9789240118164
World Health Organization. Advanced HIV disease.
World Health Organization. Updated recommendations on HIV clinical management.
No comments:
Post a Comment